Loading clinical trials...

Tissue Biomarker for Pegvisomant Action | Clinical Trials | Clareo Health

COMPLETEDNANCT01261000

Tissue Biomarker for Pegvisomant Action

Acromegaly is a disease of the pituitary gland that involves overproduction of growth hormone. Pegvisomant works by blocking binding of GH to receptors found in tissues throughout the body. Human stud...

Lead sponsor: Cedars-Sinai Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

NCT00001595 · Panhypopituitarism, Gigantism/Acromegaly, and more

Active Not RecruitingPhase 3

A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly

NCT04837040 · Acromegaly

Not Yet Recruiting

An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly

NCT07583563 · Acromegaly

COMPLETEDPhase 3

A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

NCT04125836 · Acromegaly

COMPLETEDNA

Reproducibility and Utility of OGTT in Acromegaly

NCT04066569 · Acromegaly

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 22, 2017Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment8

Start dateNov 2010

Last updatedAug 22, 2017

Condition

Acromegaly

Locations shown

Cedars-Sinai Medical Center

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 22, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions